PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20578898-3	2010	ZD6474 (Vandetanib), currently in phase III trials, suppressed tumorigenesis in MEN2 model flies, demonstrating for the first time the effectiveness of a Drosophila-based whole animal model for identifying therapeutically useful compounds.	vandetanib	0-6	Ret oncogene	Drosophila melanogaster	80-84	
20578898-3	2010	ZD6474 (Vandetanib), currently in phase III trials, suppressed tumorigenesis in MEN2 model flies, demonstrating for the first time the effectiveness of a Drosophila-based whole animal model for identifying therapeutically useful compounds.	vandetanib	8-18	Ret oncogene	Drosophila melanogaster	80-84	
15867345-0	2005	ZD6474 suppresses oncogenic RET isoforms in a Drosophila model for type 2 multiple endocrine neoplasia syndromes and papillary thyroid carcinoma.	vandetanib	0-6	Ret oncogene	Drosophila melanogaster	28-31